Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan
Background We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4‐related sclerosing cholangitis (IgG4‐SC) might be misdiagnosed as PSC. Since the clinical diagnos...
Saved in:
| Published in | Journal of hepato-biliary-pancreatic sciences Vol. 21; no. 1; pp. 43 - 50 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
Blackwell Publishing Ltd
01.01.2014
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1868-6974 1868-6982 1868-6982 |
| DOI | 10.1002/jhbp.50 |
Cover
| Abstract | Background
We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4‐related sclerosing cholangitis (IgG4‐SC) might be misdiagnosed as PSC. Since the clinical diagnostic criteria of IgG4‐SC were established in 2012, we again conducted a nationwide survey to investigate the characteristics of PSC and IgG4‐SC lacking pancreatic involvement.
Methods
The design was a questionnaire‐based, multi‐center retrospective study. The enrolled subjects were patients with PSC and IgG4‐SC without pancreatic involvement diagnosed after 2005.
Results
We enrolled 197 PSC and 43 IgG4‐SC patients without pancreatic lesions. The male dominance was significantly evident in IgG4‐SC (P = 0.006). In patients with PSC, two peaks in age distribution were clearly observed. IgG4‐SC was not detected in any patient younger than 45 years of age. At presentation, serum albumin and IgM were significantly higher in PSC, while serum IgG and IgG4 were significantly elevated in IgG4‐SC. Inflammatory bowel disease (IBD) was detected in only 68/197 PSC patients (34%). The prognosis of IgG4‐SC was considerably better than that of PSC.
Conclusion
We confirmed several interesting clinical details of PSC in Japanese patients: two peaks in the age distribution and lower prevalence of IBD. |
|---|---|
| AbstractList | Background
We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4‐related sclerosing cholangitis (IgG4‐SC) might be misdiagnosed as PSC. Since the clinical diagnostic criteria of IgG4‐SC were established in 2012, we again conducted a nationwide survey to investigate the characteristics of PSC and IgG4‐SC lacking pancreatic involvement.
Methods
The design was a questionnaire‐based, multi‐center retrospective study. The enrolled subjects were patients with PSC and IgG4‐SC without pancreatic involvement diagnosed after 2005.
Results
We enrolled 197 PSC and 43 IgG4‐SC patients without pancreatic lesions. The male dominance was significantly evident in IgG4‐SC (P = 0.006). In patients with PSC, two peaks in age distribution were clearly observed. IgG4‐SC was not detected in any patient younger than 45 years of age. At presentation, serum albumin and IgM were significantly higher in PSC, while serum IgG and IgG4 were significantly elevated in IgG4‐SC. Inflammatory bowel disease (IBD) was detected in only 68/197 PSC patients (34%). The prognosis of IgG4‐SC was considerably better than that of PSC.
Conclusion
We confirmed several interesting clinical details of PSC in Japanese patients: two peaks in the age distribution and lower prevalence of IBD. We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4-related sclerosing cholangitis (IgG4-SC) might be misdiagnosed as PSC. Since the clinical diagnostic criteria of IgG4-SC were established in 2012, we again conducted a nationwide survey to investigate the characteristics of PSC and IgG4-SC lacking pancreatic involvement. The design was a questionnaire-based, multi-center retrospective study. The enrolled subjects were patients with PSC and IgG4-SC without pancreatic involvement diagnosed after 2005. We enrolled 197 PSC and 43 IgG4-SC patients without pancreatic lesions. The male dominance was significantly evident in IgG4-SC (P = 0.006). In patients with PSC, two peaks in age distribution were clearly observed. IgG4-SC was not detected in any patient younger than 45 years of age. At presentation, serum albumin and IgM were significantly higher in PSC, while serum IgG and IgG4 were significantly elevated in IgG4-SC. Inflammatory bowel disease (IBD) was detected in only 68/197 PSC patients (34%). The prognosis of IgG4-SC was considerably better than that of PSC. We confirmed several interesting clinical details of PSC in Japanese patients: two peaks in the age distribution and lower prevalence of IBD. We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4-related sclerosing cholangitis (IgG4-SC) might be misdiagnosed as PSC. Since the clinical diagnostic criteria of IgG4-SC were established in 2012, we again conducted a nationwide survey to investigate the characteristics of PSC and IgG4-SC lacking pancreatic involvement.BACKGROUNDWe previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4-related sclerosing cholangitis (IgG4-SC) might be misdiagnosed as PSC. Since the clinical diagnostic criteria of IgG4-SC were established in 2012, we again conducted a nationwide survey to investigate the characteristics of PSC and IgG4-SC lacking pancreatic involvement.The design was a questionnaire-based, multi-center retrospective study. The enrolled subjects were patients with PSC and IgG4-SC without pancreatic involvement diagnosed after 2005.METHODSThe design was a questionnaire-based, multi-center retrospective study. The enrolled subjects were patients with PSC and IgG4-SC without pancreatic involvement diagnosed after 2005.We enrolled 197 PSC and 43 IgG4-SC patients without pancreatic lesions. The male dominance was significantly evident in IgG4-SC (P = 0.006). In patients with PSC, two peaks in age distribution were clearly observed. IgG4-SC was not detected in any patient younger than 45 years of age. At presentation, serum albumin and IgM were significantly higher in PSC, while serum IgG and IgG4 were significantly elevated in IgG4-SC. Inflammatory bowel disease (IBD) was detected in only 68/197 PSC patients (34%). The prognosis of IgG4-SC was considerably better than that of PSC.RESULTSWe enrolled 197 PSC and 43 IgG4-SC patients without pancreatic lesions. The male dominance was significantly evident in IgG4-SC (P = 0.006). In patients with PSC, two peaks in age distribution were clearly observed. IgG4-SC was not detected in any patient younger than 45 years of age. At presentation, serum albumin and IgM were significantly higher in PSC, while serum IgG and IgG4 were significantly elevated in IgG4-SC. Inflammatory bowel disease (IBD) was detected in only 68/197 PSC patients (34%). The prognosis of IgG4-SC was considerably better than that of PSC.We confirmed several interesting clinical details of PSC in Japanese patients: two peaks in the age distribution and lower prevalence of IBD.CONCLUSIONWe confirmed several interesting clinical details of PSC in Japanese patients: two peaks in the age distribution and lower prevalence of IBD. Background We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC patients, yet patients with IgG4-related sclerosing cholangitis (IgG4-SC) might be misdiagnosed as PSC. Since the clinical diagnostic criteria of IgG4-SC were established in 2012, we again conducted a nationwide survey to investigate the characteristics of PSC and IgG4-SC lacking pancreatic involvement. Methods The design was a questionnaire-based, multi-center retrospective study. The enrolled subjects were patients with PSC and IgG4-SC without pancreatic involvement diagnosed after 2005. Results We enrolled 197 PSC and 43 IgG4-SC patients without pancreatic lesions. The male dominance was significantly evident in IgG4-SC (P = 0.006). In patients with PSC, two peaks in age distribution were clearly observed. IgG4-SC was not detected in any patient younger than 45 years of age. At presentation, serum albumin and IgM were significantly higher in PSC, while serum IgG and IgG4 were significantly elevated in IgG4-SC. Inflammatory bowel disease (IBD) was detected in only 68/197 PSC patients (34%). The prognosis of IgG4-SC was considerably better than that of PSC. Conclusion We confirmed several interesting clinical details of PSC in Japanese patients: two peaks in the age distribution and lower prevalence of IBD. |
| Author | Inui, Kazuo Okazaki, Kazuichi Tsubouchi, Hirohito Takikawa, Hajime Tazuma, Susumu Tanaka, Atsushi |
| Author_xml | – sequence: 1 givenname: Atsushi surname: Tanaka fullname: Tanaka, Atsushi email: a-tanaka@med.teikyo-u.ac.jp organization: Department of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Tokyo, 173-8605, Itabashi-ku, Japan – sequence: 2 givenname: Susumu surname: Tazuma fullname: Tazuma, Susumu organization: Department of General Medicine, Hiroshima University Graduate School of Medical Science, Programs of Applied Medicine, Clinical Pharmacotherapy, Hiroshima, Japan – sequence: 3 givenname: Kazuichi surname: Okazaki fullname: Okazaki, Kazuichi organization: Third Department of Internal Medicine, Kansai Medical University, Hirakata, Japan – sequence: 4 givenname: Hirohito surname: Tsubouchi fullname: Tsubouchi, Hirohito organization: Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan – sequence: 5 givenname: Kazuo surname: Inui fullname: Inui, Kazuo organization: Department of Internal Medicine, Second Teaching Hospital, Fujita Health University, Nagoya, Japan – sequence: 6 givenname: Hajime surname: Takikawa fullname: Takikawa, Hajime organization: Department of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Tokyo, 173-8605, Itabashi-ku, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24353071$$D View this record in MEDLINE/PubMed |
| BookMark | eNp10UtPGzEQAGALgXgV8Q-qlbhUQkvHz909Am0DIUp7aOFoOevZ4HTjTe3d0vz7GiXkUKm-2KP5ZM3jhOz7ziMh5xSuKAD7uHiera4k7JFjWqoyV1XJ9nfvQhyRsxgXkA6nvOJwSI6Y4JJDQY8JTk3vOv_iLGZxCL9xnTVdyFbBLU1YZ7FuMXTR-XlWP3et8XPXu5gZb7P7-UjkAVvTo_2fcz4bm5Xx78hBY9qIZ9v7lPz48vn77V0--Tq6v72e5E4Ah9wItBZZWUlRN1Iaq0RDhamFrQ3lpsJKlIyzFJQNzKxspBK1EapkUKZ-GD8lHzb_rkL3a8DY66WLNbapIOyGqKmooBCSMpXoxT900Q3Bp-o0LUBVAEKJpN5v1TBbotXbuei3ASZwuQEvrsX1Lk9Bv65Gv65GS9Dju5tvEpLON9rFHv_stAk_tSp4IfXTdKSnD5-eiseHsZ7wv-k2kSI |
| ContentType | Journal Article |
| Copyright | 2013 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery |
| Copyright_xml | – notice: 2013 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery – notice: 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery. – notice: 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery |
| DBID | BSCLL CGR CUY CVF ECM EIF NPM K9. 7X8 |
| DOI | 10.1002/jhbp.50 |
| DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1868-6982 |
| EndPage | 50 |
| ExternalDocumentID | 3787491241 24353071 JHBP50 ark_67375_WNG_NKDW7VKJ_L |
| Genre | article Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GrantInformation_xml | – fundername: Intractable Hepato‐Biliary Disease Study Group in Japan – fundername: Ministry of Health, Labor, and Welfare of Japan |
| GroupedDBID | --- -Y2 0R~ 0VY 1OC 2JY 2~H 30V 33P 3SF 4.4 52U 52V 53G 5VS 8-1 8TC 8UJ 95. AAESR AAEVG AAHQN AAIAL AAIPD AAMMB AAMNL AANHP AANLZ AANXM AAONW AARHV AARTL AASGY AAXRX AAYCA AAZKR ABCUV ABFSG ABJNI ABJOX ABQSL ABQWH ABXGK ACAHQ ACBWZ ACBXY ACCZN ACGFS ACGOF ACMXC ACOMO ACPOU ACREN ACRPL ACSTC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADHKG ADIZJ ADKPE ADKYN ADMGS ADNMO ADOZA ADQRH ADRFC ADXAS ADZMN AEFGJ AEGNC AEIGN AEIMD AENEX AEUYR AEYWJ AEZWR AFBBN AFBPY AFEXP AFFPM AFGKR AFHIU AFLOW AFWTZ AFWVQ AGHNM AGJBK AGQPQ AGXDD AGYGG AHBTC AHBYD AHKAY AHMBA AHSBF AHWEU AIACR AIDQK AIDYY AITYG AIURR AIXLP ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMKLP AMTXH AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BGNMA BHBCM BMXJE BRXPI BSCLL C45 CSCUP DCZOG DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN EN4 F5P FEDTE FUBAC G-S GODZA GQ8 H.X HF~ HGLYW HMJXF HVGLF HZ~ IZIGR JBSCW KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LYRES M4Y MA- MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N2Q NF~ NU0 O66 O9- O93 O9I OVD P2W P9S PQQKQ Q.N QB0 QOS R89 ROL RSV S37 S3B SDE SMD SOJ SUPJJ SV3 TEORI TSV TUC VC2 WBKPD WHWMO WIH WIJ WIK WK8 WOHZO WVDHM WXSBR Z45 -5E -5G -BR AAHHS AAYZH ABTEG ACCFJ ADINQ AEEZP AEQDE AFPWT AIWBW AJBDE GQ6 SZN Z7U Z82 Z87 Z8V ~EX CGR CUY CVF ECM EIF NPM K9. 7X8 |
| ID | FETCH-LOGICAL-i4030-a4edde28954cf55ad64f14ac4dca13a9e948232ca18f0bd5f564ca46820853023 |
| ISSN | 1868-6974 1868-6982 |
| IngestDate | Fri Sep 05 07:33:37 EDT 2025 Tue Oct 07 06:47:03 EDT 2025 Wed Feb 19 01:52:28 EST 2025 Wed Jan 22 17:07:09 EST 2025 Tue Oct 28 04:14:50 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Inflammatory bowel diseases Nationwide survey Autoimmune pancreatitis Prednisolone Ursodeoxycholic acid |
| Language | English |
| License | 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-i4030-a4edde28954cf55ad64f14ac4dca13a9e948232ca18f0bd5f564ca46820853023 |
| Notes | Intractable Hepato-Biliary Disease Study Group in Japan Ministry of Health, Labor, and Welfare of Japan ark:/67375/WNG-NKDW7VKJ-L istex:CEADEF16C7863683970A46D836988AD884411DD2 ArticleID:JHBP50 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 24353071 |
| PQID | 1706900464 |
| PQPubID | 2034613 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1490745126 proquest_journals_1706900464 pubmed_primary_24353071 wiley_primary_10_1002_jhbp_50_JHBP50 istex_primary_ark_67375_WNG_NKDW7VKJ_L |
| PublicationCentury | 2000 |
| PublicationDate | January 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – month: 01 year: 2014 text: January 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan – name: Tokyo |
| PublicationTitle | Journal of hepato-biliary-pancreatic sciences |
| PublicationTitleAlternate | J Hepatobiliary Pancreat Sci |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
| References | Wiesner R, Grambsch P, Dickson E, Ludwig J, MacCarty R, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989;10:430-436. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610-615. Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229. Kaplan G, Laupland K, Butzner D, Urbanski S, Lee S. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042-1049. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125:1364-1369. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152-157. Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52:571-577. Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153-159. Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536-542. Tanaka A, Takikawa H. Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmun. 2013; doi: 10.1016/j.jaut.2013.07.005. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994;21:787-791. Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:691-692. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-1203. Kingham JG, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology. 2004;126:1929-1930. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity "autoimmune pancreatitis-associated sclerosing cholangitis". Pathol Int. 2005;55:405-411. Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. A nation-wide survey of sclerosing cholangitis. Tando. 2013;27:176-187 (in Japanese with English abstract). Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59:571-582. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99-103. Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk and outcome of primary sclerosing cholangitis. Hepatology. 2013; doi: 10.1002/hep.26565. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan-analysis of 192 cases. J Gastroenterol. 1997;32:134-137. Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008;48:939-944. Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY. Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol. 2002;17:908-913. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol. 1994;21:1061-1066. Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011;53:1590-1599. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013; doi: 10.1016/S0140-6736(13)60096-3. Farrant J, Hayllar K, Wilkinson M, Karani J, Portmann B, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Ganstroenterology. 1991;100:1710-1717. 2002; 17 2007; 102 2004; 126 2013; 27 2004; 29 2006; 32 2004; 28 2011; 53 2005; 62 2008 2007 2012; 19 1996; 38 1994; 21 2013; 59 1991; 100 1989; 10 1997; 32 2008; 48 2013 2008; 134 2003; 125 2005; 55 2010; 52 1998; 33 |
| References_xml | – reference: Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013; doi: 10.1016/S0140-6736(13)60096-3. – reference: Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011;53:1590-1599. – reference: Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715. – reference: Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153-159. – reference: Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-1203. – reference: Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59:571-582. – reference: Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan-analysis of 192 cases. J Gastroenterol. 1997;32:134-137. – reference: Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610-615. – reference: Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229. – reference: Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52:571-577. – reference: Farrant J, Hayllar K, Wilkinson M, Karani J, Portmann B, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Ganstroenterology. 1991;100:1710-1717. – reference: Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008;48:939-944. – reference: Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. A nation-wide survey of sclerosing cholangitis. Tando. 2013;27:176-187 (in Japanese with English abstract). – reference: Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:691-692. – reference: Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125:1364-1369. – reference: Wiesner R, Grambsch P, Dickson E, Ludwig J, MacCarty R, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989;10:430-436. – reference: Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity "autoimmune pancreatitis-associated sclerosing cholangitis". Pathol Int. 2005;55:405-411. – reference: Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY. Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol. 2002;17:908-913. – reference: Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536-542. – reference: Tanaka A, Takikawa H. Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmun. 2013; doi: 10.1016/j.jaut.2013.07.005. – reference: Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99-103. – reference: Kingham JG, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology. 2004;126:1929-1930. – reference: Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol. 1994;21:1061-1066. – reference: Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk and outcome of primary sclerosing cholangitis. Hepatology. 2013; doi: 10.1002/hep.26565. – reference: Kaplan G, Laupland K, Butzner D, Urbanski S, Lee S. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102:1042-1049. – reference: Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994;21:787-791. – reference: Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152-157. – volume: 38 start-page: 610 year: 1996 end-page: 615 article-title: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis publication-title: Gut – volume: 21 start-page: 787 year: 1994 end-page: 791 article-title: Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver publication-title: J Hepatol – start-page: 673 year: 2007 end-page: 684 – year: 2013 article-title: Primary sclerosing cholangitis publication-title: Lancet – volume: 29 start-page: 153 year: 2004 end-page: 159 article-title: Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients publication-title: Hepatol Res – volume: 102 start-page: 691 year: 2007 end-page: 692 article-title: IgG4‐related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis publication-title: Am J Gastroenterol – volume: 17 start-page: 908 year: 2002 end-page: 913 article-title: Clinical profile of primary sclerosing cholangitis in Singapore publication-title: J Gastroenterol Hepatol – volume: 19 start-page: 536 year: 2012 end-page: 542 article-title: Clinical diagnostic criteria of IgG4‐related sclerosing cholangitis 2012 publication-title: J Hepatobiliary Pancreat Sci. – year: 2013 article-title: Geoepidemiology of primary sclerosing cholangitis: a critical review publication-title: J Autoimmun – volume: 126 start-page: 1929 year: 2004 end-page: 1930 article-title: Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom publication-title: Gastroenterology – volume: 21 start-page: 1061 year: 1994 end-page: 1066 article-title: Risk factors in primary sclerosing cholangitis publication-title: J Hepatol – volume: 10 start-page: 430 year: 1989 end-page: 436 article-title: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis publication-title: Hepatology – volume: 102 start-page: 1042 year: 2007 end-page: 1049 article-title: The burden of large and small duct primary sclerosing cholangitis in adults and children: a population‐based analysis publication-title: Am J Gastroenterol – volume: 32 start-page: 134 year: 1997 end-page: 137 article-title: Primary sclerosing cholangitis in Japan—analysis of 192 cases publication-title: J Gastroenterol – volume: 134 start-page: 706 year: 2008 end-page: 715 article-title: Immunoglobulin G4‐associated cholangitis: clinical profile and response to therapy publication-title: Gastroenterology – volume: 59 start-page: 571 year: 2013 end-page: 582 article-title: Update on primary sclerosing cholangitis publication-title: J Hepatol – volume: 62 start-page: 152 year: 2005 end-page: 157 article-title: Immunoglobulin G4‐related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? publication-title: Gastrointest Endosc – volume: 52 start-page: 571 year: 2010 end-page: 577 article-title: Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden publication-title: Hepatology – volume: 32 start-page: 229 year: 2006 article-title: Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography publication-title: Pancreas – year: 2008 – volume: 48 start-page: 939 year: 2008 end-page: 944 article-title: Incidence and mortality of primary sclerosing cholangitis in the UK: a population‐based cohort study publication-title: J Hepatol – volume: 125 start-page: 1364 year: 2003 end-page: 1369 article-title: Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community publication-title: Gastroenterology – volume: 28 start-page: 1193 year: 2004 end-page: 1203 article-title: IgG4‐related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis‐associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? publication-title: Am J Surg Pathol – volume: 100 start-page: 1710 year: 1991 end-page: 1717 article-title: Natural history and prognostic variables in primary sclerosing cholangitis publication-title: Ganstroenterology – volume: 33 start-page: 99 year: 1998 end-page: 103 article-title: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population publication-title: Scand J Gastroenterol – volume: 27 start-page: 176 year: 2013 end-page: 187 article-title: A nation‐wide survey of sclerosing cholangitis publication-title: Tando. – year: 2013 article-title: Population‐based epidemiology, malignancy risk and outcome of primary sclerosing cholangitis publication-title: Hepatology – volume: 55 start-page: 405 year: 2005 end-page: 411 article-title: Distinct clinicopathological entity “autoimmune pancreatitis‐associated sclerosing cholangitis” publication-title: Pathol Int – volume: 53 start-page: 1590 year: 2011 end-page: 1599 article-title: Incidence of primary sclerosing cholangitis: a systematic review and meta‐analysis publication-title: Hepatology |
| SSID | ssj0000313930 |
| Score | 2.3932302 |
| Snippet | Background
We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of... We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of Japanese PSC... Background We previously conducted nationwide surveys for primary sclerosing cholangitis (PSC) in Japan, and demonstrated several characteristic features of... |
| SourceID | proquest pubmed wiley istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 43 |
| SubjectTerms | Adult Aged Autoimmune Diseases - complications Autoimmune Diseases - epidemiology Autoimmune Diseases - therapy Autoimmune pancreatitis Cholangitis, Sclerosing - complications Cholangitis, Sclerosing - epidemiology Cholangitis, Sclerosing - therapy Female Humans Immunoglobulin G - immunology Inflammatory bowel disease Inflammatory bowel diseases Japan Male Middle Aged Nationwide survey Prednisolone Prognosis Retrospective Studies Surveys and Questionnaires Ursodeoxycholic acid |
| Title | Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan |
| URI | https://api.istex.fr/ark:/67375/WNG-NKDW7VKJ-L/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjhbp.50 https://www.ncbi.nlm.nih.gov/pubmed/24353071 https://www.proquest.com/docview/1706900464 https://www.proquest.com/docview/1490745126 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1868-6982 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000313930 issn: 1868-6974 databaseCode: AFBBN dateStart: 19970301 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6F9MIFgXgZClqkikvkYDvr17EB2pCgiENKe7PW63VjotpVbLcoP5FfxewD2wmNVLiskvUkfszsfDPj2RmEjhhLw5jHgUnC2IeBEzOmDihDQKMRZ8RxUpltMfcmZ2R64V70er86WUt1FQ_Z5s59Jf_DVZgDvopdsv_A2eZPYQI-A39hBA7DeC8eq6LWt1nCB2W9vuEq-fJaF5AogRowUO6qFR6s6EyUqZLMXy5PiSm3sYC9uYcuywdTQNJ8j_m6BByrClPk1sLJTCBU9icbaFBtjPUFzelKhW-rsi6XWXtgU19RnRtUX9VNwHdFN1S1054BScY6PynruBD9WyRkZutiCRqpG7mwyU7kYidCqSJubS6T0MaBF5heqNr4DHl3LthS4WqT9ZaoKn2sSkBpZFcVbv_CDFWD9scyvh4qiu2q3Dto2eQw0vVKJMX5bnQ-P43ms0_n_vfZNPr6AB04gDBWHx0cn4zH8ybiJ6pkhrL5TXNfahe3uIIP-vzgI4nl_fMuh2fbf5IG0OIxeqRZj4-VGD5BPZ4_RbwVQaxEEIMIYi2CuBUt3BEtDCKIuyK4jy7LsRTBZ-js5PPi48TUnTvMjABqmJRwgE3w5V3CUteliUdSm1BGEkbtEQ15SEAVOPAlSK04cVPXI4wSLxAdY0Ubq-eonxc5f4kwGKwk9rmdWL4DzjWnAfecdORTzkPmE8dA7-UDi_SdRfv4YqDDP0800mu4jETxqFC-3jfQu-YwaFjx2ozmvKiBhogAEhjGnoFeKE40J3PA2wCUtA10JFnTHFDVwJ1IsDVyrWg6GX9zrVf3vdjX6GG7Yg5Rv1rX_A1Yv1X8VovVb_OMuQM |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nationwide+survey+for+primary+sclerosing+cholangitis+and+IgG4-related+sclerosing+cholangitis+in+Japan&rft.jtitle=Journal+of+hepato-biliary-pancreatic+sciences&rft.au=Tanaka%2C+Atsushi&rft.au=Tazuma%2C+Susumu&rft.au=Okazaki%2C+Kazuichi&rft.au=Tsubouchi%2C+Hirohito&rft.date=2014-01-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1868-6974&rft.eissn=1868-6982&rft.volume=21&rft.issue=1&rft.spage=43&rft.epage=50&rft_id=info:doi/10.1002%2Fjhbp.50&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_NKDW7VKJ_L |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1868-6974&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1868-6974&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1868-6974&client=summon |